ClassID:

96168

C07F9/65128 - CPC Classification

Classification description:

Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds; Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms; Six-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems

Recent Application in this class:
#1
20250171452
2025-05-29

TRYPTANTHRIN DERIVATIVES AND USES THEREOF

#2
20250059218
2025-02-20

ENPP1 Inhibitors and Methods of Modulating Immune Response

#3
20240360163
2024-10-31

Nucleoside Prodrugs and Uses Related Thereto

#4
20240254151
2024-08-01

SOS1 INHIBITOR CONTAINING PHOSPHORUS

#5
20220298185
2022-09-22

Nucleoside prodrugs and uses related thereto

#6
20220289775
2022-09-15

ENPP1 Inhibitors and Methods of Modulating Immune Response

#7
20220056052
2022-02-24

QUINAZOLINE DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS

#8
20200147083
2020-05-14

Small molecule modulators of human sting

#9
20200095269
2020-03-26

Organic electronic device comprising an organic semiconductor layer and a device

#10
20170044203
2017-02-16

Purine derivatives as CD73 inhibitors for the treatment of cancer

#11
20160276600
2016-09-22

Heterocyclic compound and organic light emitting device using the same

#12
20160158390
2016-06-09

Methods for Tumor Diagnosis and Therapy

#13
20150368246
2015-12-24

Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C

#14
20150175641
2015-06-25

Phosphoramidic acid prodrugs of 5-[5-phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl] pyridine-3-sulfonamide

#15
20150126550
2015-05-07

Pharmaceutical uses of 6-amino quinazoline or 3-cyano quinoline derivatives

#16
20140378453
2014-12-25

2-(2-hydroxybiphenyl-3-yl)-1-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors

#17
20120213701
2012-08-23

Methods for tumor diagnosis and therapy

#18
20120196833
2012-08-02

Phosphorus containing quinazoline compounds and methods of use

#19
20120165352
2012-06-28

6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof

#20
20110269806
2011-11-03

2-(2-hydroxybiphenyl-3-yl)-1-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors

#21
20090285755
2009-11-19

Compounds for tumor diagnosis and therapy

#22
20090054432
2009-02-26

2-(2-Hydroxybiphenyl-3-yl)-1H-Benzoimidazole-5-Carboxamidine Derivatives as Factor VIIA Inhibitors

#23
20080241589
2008-10-02

ORGANIC ELECTROLUMINESCENT DEVICE

#24
20070191333
2007-08-16

Antibacterial agents

#25
20070190523
2007-08-16

Method and compositions for identifying anti-hiv therapeutic compounds

#26
20070078081
2007-04-05

Antiviral compounds

#27
20070010489
2007-01-11

Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds

#28
20060205942
2006-09-14

2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors

#29
20060128692
2006-06-15

Non nucleoside reverse transcriptase inhibitors

#30
20060115815
2006-06-01

Method and compositions for identifying anti-hiv therapeutic compounds

#31
20060089354
2006-04-27

Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators

#32
20060058325
2006-03-16

Therapeutic quniazoline derivatives

#33
20050239054
2005-10-27

Method and compositions for identifying anti-HIV therapeutic compounds

#34
20050209197
2005-09-22

Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds

#35
20050197320
2005-09-08

Non nucleoside reverse transcriptase inhibitors